Effect of russian ß2–agonists on airway hyperresponsiveness
Abstract
In this study we compared the effect of oral long-acting salbutamol – saltos (6 mg), inhaled salbutamol, salgem (500 mg), or placebo on the airway responsiveness to histamine. Twenty eight patients with mild bronchial asthma in stable state were observed. The study had a double-blind, crossover, placebo-controlled design. The challenge test with hystamine was peformed before and after administration of the studied medications.
The provacative concentration producing a 20% fall in forced expiratory volume in one second was significantly increased after administration of ß2–agonists than of placebo.
We conclude that Russian ß2–agonists have a significant bronchoprotective effect. The duration of bronchoprotective effect for saltos is 9 h, for salgem is 1.5 h.
References
1. Орлов С.Н., Рябова К.Г., Покудин Н.И., Баранова И.А., Чучалин А.Г. Механизмы адренергической регуляции функции легких: достижения и перспективы // Сальбутамол / Под ред. А.Г. Чучалина, И. Хамида. — М.: Фармединфо, 1992. — С. 147—165.
2. Официальный бюллетень Европейского респираторного общества. Восприимчивость дыхательных путей // Пульмонология. — 1993. — Приложение. — С. 60—86.
3. Чучалин А.Г. Бронхиальная астма: глобальная стратегия // Тер. арх. — 1994. — № 3. — С. З—8.
4. Baker A.J., Fuller R.W. Anti-inflammatory effect of salmeterol on human alveolar macrophages // Am. Rev. Respir. Dis. — 1990. — Vol. 141, № 4. — P. A394.
5. Church M .K., Hiroi J. Inhibiion of IgE-dependent histamine release from dispersed lung mast cells by antiallergic drugs and salbutamol // Br. J. Pharmacol. — 1987. — Vol. 90, № 2. — P. 421—429.
6. Church M.K., Young K.D. The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromasine // Ibid. — 1983. — Vol. 78, № 4. — P. 671—769.
7. Cochrane G.M. Bronchial asthma and the role of beta-2-agonists // Lung. — 1990. — Vol. 168, Suppl. — P. 66—70.
8. Dahl R., Pedersen B., Venge P. Bronchoalveolar lavage studies // Eur. Respir. Rev. — 1991. — Vol.l, № 4. — P. 272—275.
9. Derom E.Y., Pauwels R., Van der Straeten M. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours // J. Allergy Clin. Immunol. — 1992. — Vol. 89. — P. 811—815.
10. Global initiative for asthma. Global strategy for asthma management and prevention NHLBI/WHO workshop report. March 1993. — National Heart, Lung and Blood Institute, National Institute of Health. January 1995. — Washington, 1995.
11. Gongora H.C., Wisniewski A .F.Z., Tatterjield A.E. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects // Am. Rev. Respir. Dis. — 1991. — Vol. 144. — P. 626—629.
12. Howarth P.H., Djukanovic R., Walls A., Wilson J., Roche W., Holgate S.T. Future developments in anti-inflammatory studies // Eur. Respir. Rev. — 1991. — Vol.l, № 4. — P. 276—281.
13. Johnson M. The pharmacology of salmeterol // Lung. — 1990. — Vol. 168, Suppl. — P. 115—119.
14. Johnson M. The preclinical pharmacology of salmeterol: non-bronchodilator effects // Eur. Respir. Rev. — 1991. — Vol. l, № 4. — P. 257—260.
15. Juniper E.F., Cockrojt D.W., Hargreaue F.E. Histamine and Methacholine Inhalation Tests: Tidal Breathing Method. Laboratory Procedure and Standardisation. — Lund; AB Draco, 1991.
16. Kerrebijn K.F. Long-term drug treatment of asthma in children // Lung. — 1990. — Vol. 168, Suppl. — P. 142—153.
17. Malo J.L., Cartier A., Ghezzo H., Trudeau C., LArcheueque J. Duree de leffet bronchoprotecteur du salmeterol dans lasthme induit par Ihyperventilation dair froid sec // Rev. Mai. Respir. — 1992. — Vol. 9. — P. R19—R21.
18. Pauwels R., Joos G., Van der Straeten M. Bronchial hyperresponsiveness is not bronchial responsiveness is not bronchial asthma // Clin. Allergy. — 1988. — Vol.18. — P. 317—321.
19. Quanjer Ph.H., Tammeling G.L., Cotes J.E., Pedersen O.F., Peslin R. Lung volumes and ventilatory flows // Eur. Respir. J. — 1993. — Vol. 6. — P. 4—40.
20. Roscheto P., Roberts N.M., Roger D.T., Barnes P.J. Effect of antiasthma drugs on microvascular leakage in guinea pig airways // Am. Rev. Respir. Dis. — 1989. - Vol. 139, № 2. — P. 416—421.
21. Sterk P. J., Fabbri L.M., Quanjer Ph.H., Cockroft D. W., OByrne P.M., Anderson S.D., Juniper E.F., Malo J.-L. Airway responsiveness // Eur. Respir. J. — 1993. — Vol.6, Suppl. 6. — P. 55—64.
22. Twentyman O.P. Finnerty J.P., Harris A., Palmer J., Holgate S.T. Protection against allergen-induced asthma by salmeterol // Lancet. — 1990. — Vol. 336, № 8727. — P. 1338—1342.
Review
For citations:
Cherniak A.V. Effect of russian ß2–agonists on airway hyperresponsiveness. PULMONOLOGIYA. 1996;(4):46-51. (In Russ.)